NEW YORK (GenomeWeb) – Perthera said today that it is partnering with stomach cancer non-profit Hope for Stomach Cancer to provide its Precision Cancer Analysis (PCA) service to all HSC patients at no cost to them.

Through its PCA service, Perthera will facilitate molecular profiling of Hope for Stomach Cancer patients, providing genomic, proteomic, and phosphoproteomic analyses of their tumors along with treatment recommendations based upon this molecular information.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.